Modest Decline Seen in Portal Messaging With Billing Implementation
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- Implementation of e-visit billing for responding to patient-initiated messages that require substantive medical decision-making is associated with a modest decrease in patient-initiated portal message volume, according to a study published online Dec. 31 in the Annals of Internal Medicine.
Shannon M. Dunlay, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the effect of billing eligible patient-initiated portal messages as e-visits in a retrospective observation pre-post comparison and prospective survey. The volume of patient-initiated medical advice message threads was compared preimplementation versus postimplementation of e-visit billing. An online survey was used to assess health system provider perceptions of e-visit billing.
The researchers found that the volume of patient-initiated medical advice message threads decreased by 8.8 percent in the six months after e-visit billing implementation (Aug 18, 2023, through Feb. 18, 2024) compared with the same dates the year prior. Overall, 5,183 medical advice messages (0.3 percent) were billed. Patients who proceeded with sending a message had no difference in seven-day use of emergency services compared with those who did not send a message after viewing the billing disclaimer on the patient portal. Overall acceptance of e-visit billing was reported by providers, but they expressed concerns relating to increased workload with the current process.
"As digital health care practices continue to evolve, opportunities exist to optimize interactions to maximize patient satisfaction and outcomes and minimize care team burden and burnout," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-31 12:00
Read more
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
- FDA Approves Gemtesa for Overactive Bladder in Men With BPH
- Team Sports Score Big Points for Your Child's Brain, Study Finds
- 1 in 3 Older Americans Say They Feel Lonely, Poll Finds
- Certain Foods May Cut Risk for Rheumatoid Arthritis
- Blood Pressure Ups & Downs May Harm Seniors' Thinking
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions